The gut microbiota-short-chain fatty acid-inflammation axis in Parkinson's disease motor dysfunction: mechanisms and future of dietary interventions

Abstract

Parkinson's disease (PD) is a neurodegenerative disorder characterized mainly by motor dysfunction that severely affects quality of life. In recent years, the gut microbiota and its metabolites, short-chain fatty acids (SCFAs), have become a focus in PD research.

The paper